Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief

References

• Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. Jama. 2004;292(11):1333–1340.
   PubMed Web of Science ®Google Scholar
• Reid AH, Taubenberger JK, Fanning TG. The 1918 Spanish influenza: integrating history and biology. Microbes Infect. 2001;3(1):81–87.
   PubMed Web of Science ®Google Scholar
• Gavigan P, McCullers JA. Influenza: annual seasonal severity. Curr Opin Pediatr. 2019;31(1):112–118.
   PubMed Web of Science ®Google Scholar
• Jackson L, Jackson ML, Phillips CH, et al. Interim adjusted estimates of seasonal influenza vaccine effectiveness—United States, February 2013. MMWR Morb Mortal Wkly Rep. 2013;62(7):119.
   PubMed Web of Science ®Google Scholar
• Keitel W, Grohskopf L, Bresee J, et al. Prevention and control of influenza with vaccines: interim recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013. MMWR Morb Mortal Wkly Rep. 2013;62(18):356.
   PubMed Web of Science ®Google Scholar
• Baranovich T, Webster RG, Govorkova EA. Fitness of neuraminidase inhibitor-resistant influenza A viruses. Curr Opin Virol. 2011;1(6):574–581.
   PubMed Web of Science ®Google Scholar
• Leang S-K, Deng Y-M, Shaw R, et al. Influenza antiviral resistance in the Asia-Pacific region during 2011. Antiviral Res. 2013;97(2):206–210.
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med. 2008;121(4):258–264.
   PubMed Web of Science ®Google Scholar
• Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9(10):601–610.
   PubMed Web of Science ®Google Scholar
• Glaser CA, Winter K, DuBray K, et al. A population-based study of neurologic manifestations of severe influenza A (H1N1) pdm09 in California. Clinl Infect Dis. 2012;55(4):514–520.
   PubMed Web of Science ®Google Scholar
• Lucerna A, Lee J, Espinosa J. Syncope and influenza B: a case of an arresting association. Case Rep Emerg Med. 2018; Aug 2; 2018.
   Google Scholar
• Abramson JS, Mills EL. Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Clinl Infect Dis. 1988;10(2):326–341.
   Google Scholar
• Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. Jama. 2013;309(3):275–282.
   PubMed Web of Science ®Google Scholar
• Rynda-Apple A, Robinson KM, Alcorn JF. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect Immun. 2015;83(10):3764–3770.
   PubMed Web of Science ®Google Scholar
• Metersky ML, Masterton RG, Lode H, et al. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Inter J Infect Dis. 2012;16(5):e321–e331.
   PubMed Web of Science ®Google Scholar
• Metzger DW, Sun K. Immune dysfunction and bacterial coinfections following influenza. J Immunol. 2013;191(5):2047–2052.
   PubMed Web of Science ®Google Scholar
• Pittet LA, Hall-Stoodley L, Rutkowski MR, et al. Influenza virus infection decreases tracheal mucociliary velocity and clearance of streptococcus pneumoniae. Am J Respir Cell Mol Biol. 2010;42(4):450–460.
   PubMed Web of Science ®Google Scholar
• Smith AM, Adler FR, Ribeiro RM, et al. Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathog. 2013;9(3):e1003238.
   PubMed Web of Science ®Google Scholar
• Ghoneim HE, Thomas PG, McCullers JA. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol. 2013;191(3):1250–1259.
   PubMed Web of Science ®Google Scholar
• Hartshorn KL, Liou LS, White MR, et al. Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J Immunol. 1995;154(8):3952–3960.
   PubMed Web of Science ®Google Scholar
• Smith AM, Smith AP. A critical, nonlinear threshold dictates bacterial invasion and initial kinetics during influenza. Sci Rep. 2016;6:38703.
   PubMed Web of Science ®Google Scholar
• Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004;23(1):S87–S97.
   PubMed Web of Science ®Google Scholar
• Colamussi ML, White MR, Crouch E, et al. Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood. 1999;93(7):2395–2403.
   PubMed Web of Science ®Google Scholar
• McNamee LA, Harmsen AG. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary streptococcus pneumoniae infection. Infect Immun. 2006;74(12):6707–6721.
   PubMed Web of Science ®Google Scholar
• Engelich G, White M, Hartshorn KL. Neutrophil survival is markedly reduced by incubation with influenza virus and streptococcus pneumoniae: role of respiratory burst. J Leukoc Biol. 2001;69(1):50–56.
   PubMed Web of Science ®Google Scholar
• McCullers JA, Rehg JE. Lethal synergism between influenza virus and streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis. 2002;186(3):341–350.
   PubMed Web of Science ®Google Scholar
• van der Sluijs KF, van Elden LJ, Nijhuis M, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol. 2004;172(12):7603–7609.
   PubMed Web of Science ®Google Scholar
• Seki M, Yanagihara K, Higashiyama Y, et al. Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J. 2004;24(1):143–149.
   PubMed Web of Science ®Google Scholar
• Smith MW, Schmidt JE, Rehg JE, et al. Induction of pro-and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. Comp Med. 2007;57(1):82–89.
   PubMed Web of Science ®Google Scholar
• Almaghrabi R. Sustained emergence of influenza A H1N1 and epidemiologic aspects of H1N1 in Saudi Arabia. Int J Ped Neo Heal. 2017;1(4):96–101.
   Google Scholar
• Dunning J, Baillie JK, Cao B, et al. Antiviral combinations for severe influenza. Lancet Infect Dis. 2014;14(12):1259–1270.
   PubMed Web of Science ®Google Scholar
• Hui DS, Lee N, Chan PK. Adjunctive therapies and immunomodulatory agents in the management of severe influenza. Antiviral Res. 2013;98(3):410–416.
   PubMed Web of Science ®Google Scholar
• Kakeya H, Seki M, Izumikawa K, et al. Efficacy of combination therapy with oseltamivir phosphate and azithromycin for influenza: a multicenter, open-label, randomized study. PLoS One. 2014;9(3):e91293.
   PubMed Web of Science ®Google Scholar
• Min J-Y, Jang YJ. Macrolide therapy in respiratory viral infections. Mediators Inflamm. 2012; 2012: 649570.
   PubMed Web of Science ®Google Scholar
• Karlström Å, Boyd K, English BK, et al. Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. J Infect Dis. 2009;199(3):311–319.
   PubMed Web of Science ®Google Scholar
• Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A (H1N1) virus and bacterial co-infection in the United States. Crit Care Med. 2012;40(5):1487.
   PubMed Web of Science ®Google Scholar
• Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. Jama. 2009;302(17):1872–1879.
   PubMed Web of Science ®Google Scholar
• Perez-Padilla R, De La Rosa-zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361(7):680–689.
   PubMed Web of Science ®Google Scholar
• Rello J, Rodríguez A, Ibañez P, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1) v in Spain. Crit Care. 2009;13(5):R148.
   PubMed Web of Science ®Google Scholar
• Webb S, Pettilä V, Seppelt I, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361(20):1925–1934.
   PubMed Web of Science ®Google Scholar
• Choi S-H, Hong S-B, Ko G-B, et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med. 2012;186(4):325–332.
   PubMed Web of Science ®Google Scholar
• Póvoa P, Coelho L. Clinical significance of viral detection in critically ill patients. More questions than answers. Am Thorac Soc. 2019;199 (4):411–413.
   Google Scholar
• Roush SW, McIntyre L, Baldy LM. Manual for the surveillance of vaccine-preventable diseases. Atlanta. 2008;4: ch 14.
   Google Scholar
• Vemula SV, Zhao J, Liu J, et al. Current approaches for diagnosis of influenza virus infections in humans. Viruses. 2016;8(4):96.
   PubMed Web of Science ®Google Scholar
• Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(1):1–24.
   PubMedGoogle Scholar
• Niederman MS. Community-acquired pneumonia. 2015;313(7):677–686.
   Google Scholar
• Hyattsville M, Statistics N. Health, United States, 2006 with chartbook on trends in the health of Americans. Hyattsville, MD: 2007.
   Google Scholar
• MacIntyre CR, Chughtai AA, Barnes M, et al. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a (H1N1) pdm09. BMC Infect Dis. 2018;18(1):637.
   PubMedGoogle Scholar
• López-Boado YS, Rubin BK. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Curr Opin Pharmacol. 2008;8(3):286–291.
   PubMed Web of Science ®Google Scholar
• Lee N, Chan P, Wong CK, et al. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A (H1N1) virus pneumonia. Antivir Ther. 2011;16(2):237.
   PubMed Web of Science ®Google Scholar
• To KK, Hung IF, Li IW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clinl Infect Dis. 2010;50(6):850–859.
   PubMed Web of Science ®Google Scholar
• Bradley-Stewart A, Jolly L, Adamson W, et al. Cytokine responses in patients with mild or severe influenza A (H1N1) pdm09. J Clin Virol. 2013;58(1):100–107.
   PubMed Web of Science ®Google Scholar
• Xi-zhi JG, Thomas PG, editors. New fronts emerge in the influenza cytokine storm. Seminars in immunopathology. Springer; 2017;39(5):541–550.
   Google Scholar
• Bermejo-Martin JF, de Lejarazu RO, Pumarola T, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 2009;13(6):R201.
   PubMed Web of Science ®Google Scholar
• Ison MG. Adjuvant immunosuppression in the management of severe influenza: friend or foe? Crit Care Med. 2014;42(2):457–459.
   PubMed Web of Science ®Google Scholar
• Lee N, Wong C, Chan P, et al. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clinl Infect Dis. 2007;45(6):723–731.
   PubMed Web of Science ®Google Scholar
• Lee N, Wong CK, Chan PK, et al. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PloS One. 2011;6(10):e26050.
   PubMed Web of Science ®Google Scholar
• Lee N, Wong C-K, Chan MC, et al. Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: a randomized controlled trial. Antiviral Res. 2017;144:48–56.
   PubMed Web of Science ®Google Scholar
• Martin-Loeches I, Bermejo-Martin J, Valles J, et al. Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia. Intensive Care Med. 2013;39(4):693–702.
   PubMed Web of Science ®Google Scholar
• Hung IF, To KK, Chan JF, et al. Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A (H3N2) infection: an open-label randomized, controlled, phase IIb/III trial. Chest. 2017;151(5):1069–1080.
   PubMed Web of Science ®Google Scholar
• Walkey AJ, Wiener RS. Macrolide antibiotics and survival in patients with acute lung injury. Chest. 2012;141(5):1153–1159.
   PubMed Web of Science ®Google Scholar
• Teng F, Liu X, Guo S-B, et al. Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients. J Infect Chemother. 2019;25(2):129–136.
   PubMed Web of Science ®Google Scholar
• Martín-Loeches I, Sanchez-Corral A, Diaz E, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A (H1N1) virus. Chest. 2011;139(3):555–562.
   PubMed Web of Science ®Google Scholar